2023 MSK Pulmo-Oncology Symposium

Pulmo-Oncology is an emerging discipline that has great importance to the clinical care of cancer patients. The respiratory system is often impacted by direct cancer involvement, infections, and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

In this inaugural Symposium, clinical experts from Memorial Sloan Kettering (MSK) and other institutions will present an up-to-date overview of cutting-edge cancer therapies and best practice strategies in the evaluation and management of lung disease. The purpose of this Symposium is to provide a state-of-the-art, case-based, multidisciplinary curriculum that addresses selected topics relevant to the respiratory health of patients with cancer.

Online Syllabus

Registered attendees will receive access to an online syllabus after the course, which includes select PDFs of the faculty presentations (slides) and recorded videos from the course. MSK CME will email attendees when this becomes available. Attendees must check in on the day of the Symposium in order to receive access to the syllabus.

Who Should Attend

1. Explain the role of pulmonologist in diagnosis and management of lung cancer
2. Identify state of the art treatment strategies for management of lung cancer and check point inhibitor pneumonitis
3. Implement strategies for diagnosis and management of infectious and non infectious complications of stem cell transplant
4. Implement approaches to symptom management of cough and malignant pleural effusion related dyspnea
5. Explain clinical significance of interstitial lung abnormalities and pulmonary fibrosis in lung cancer management

Virtual Registration Fees

• Physicians (MDs, PhDs, PharmDs, and DOs): $150
• Advanced Practice Providers: $100
• Nurses, Residents, Fellows, and Other Healthcare Providers: $75
• Industry Professionals*: $265
• MSK Employees: Complimentary

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend this Symposium. If you are a member of one of these groups, contact [email protected] for details and a promotion code. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

This program will be delivered through Zoom. Access details, including a link to Zoom and faculty disclosures, will be sent to  registrants prior to the start of the Symposium.

Cancellation Policy

If you wish to cancel your participation in this Symposium, you must email [email protected] at least seven (7) days prior to the start of the program, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the Symposium are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any Symposium due to unforeseen circumstances. In the unlikely event we must cancel or postpone this program, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MSK Symposium Directors

Alexander I. Geyer, MD
Assistant Attending, Clinical Director
Assistant Professor of Clinical Medicine 
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Leontine L.J. van Elden, MD, PhD
Associate Attending
Assistant Professor of Clinical Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Christina M. Hess, MS, MSN
Nurse Practitioner, Pulmonary Service
Memorial Sloan Kettering Cancer Center

MSK Planning Committee

Mohit Chawla, MD, FCCP
Chief, Pulmonary Service
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Louise M. Cunningham, SLPD, CCC-SLP, BCS-S
Speech-Language Pathologist
Manager Speech and Swallowing
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Leslie E. Kao, MD, MS
Fellow, Pulmonary and Critical Care Medicine Fellowship
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Invited Faculty 

Karmela Kim Chan, MD
Assistant Attending Physician, Assistant Professor of Medicine
Associate Program Director, Adult Rheumatology Fellowship Program
Hospital for Special Surgery
Weill Cornell Medical Center-New York Presbyterian
New York, NY 

Charles A. Powell, MD, MBA
Professor of Medicine
System Division Chief for Pulmonary, Critical Care and Sleep Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

Suhail Raoof, MD
Professor of Medicine and Radiology
Director, Lung Institute
Phyllis and William Mack Chair of Pulmonary Medicine
Northwell Health
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
New York, NY

Willemijn Theelen, MD, PhD
Pulmonologist
Netherlands Cancer Institute (NKI)
Amsterdam, Netherlands

MSK Faculty 

Gary Deng, MD, PhD
Attending, Medical Director
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Andrew Harris, MD
Associate Attending
Memorial Sloan Kettering Cancer Center

Or Kalchiem-Dekel, MD
Assistant Attending, Instructor of Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Adam J. Schoenfeld, MD
Assistant Attending, Assistant Professor of Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Zainab Shahid, MBBS
Associate Attending
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Valeria Silva Merea, MD
Laryngologist
Director, Speech and Hearing Center
Assistant Attending Surgeon
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Stacy Stabler, MD, PhD
Associate Attending, Assistant Professor of Clinical Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Elizabeth Yogiaveetil, MD
Assistant Attending,  Assistant Professor of Clinical Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.